GRI BIO, Inc.
biologics manufacturing platform for biopharmaceuticals
- Sector
- Biotech
- Headquarters
- LA JOLLA, CA
- Latest Form D
- $762K, Oct 2024
- Total capital
- $16.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $16.3M
- 2 Form D · last Oct 2024
- 24 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 9
- 4 pending · first 2018
- Rank in peer group#26 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$762K
- Private capital raisedForm D · SEC · 1st filing$15.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#26 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- ABRAHAM MARC VAN WYCKDirectorNamed in SEC Form D filings
- ALBERT MARC AGROExecutive Officer, DirectorNamed in SEC Form D filings
- Albert Kumar ArgoExecutive Officer, DirectorNamed in SEC Form D filings
- Camilla Marc SimpsonDirectorNamed in SEC Form D filings
- David Marc BakerDirectorNamed in SEC Form D filings
- David Kumar SzekeresDirectorNamed in SEC Form D filings
Show all 14 people
- GERALD MARC YAKATANDirectorNamed in SEC Form D filings
- Leanne Marc KellyExecutive Officer, DirectorNamed in SEC Form D filings
- Roelof Kumar RongenDirectorNamed in SEC Form D filings
- SEAN G EDWARDSExecutive OfficerNamed in SEC Form D filings
- Vipin Kumar ChaturvediExecutive Officer, DirectorNamed in SEC Form D filings
- VIPIN MARC KUMARDirectorNamed in SEC Form D filings
- Walter Marc HertzExecutive Officer, DirectorNamed in SEC Form D filings
- W MARC HERTZExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 9 granted of 13- GrantedOxygenated And Amino- Or Ammonium-containing Phosphonic Acid Derivatives And Their Medical UseUSPTOUS 12,528,775
- GrantedPrevention And Treatment Of Inflammatory ConditionsUSPTOUS 11,660,309
- GrantedHydroxy-substituted Amino And Ammonium Derivatives And Their Medical UseUSPTOUS 11,564,895
Show all 13 patent records
- Oxygenated And Amino- Or Ammonium-containing Phosphonic Acid Derivatives And Their Medical UseJan 20, 2026 · US 12,528,775Granted
- Prevention And Treatment Of Inflammatory ConditionsMay 30, 2023 · US 11,660,309Granted
- Hydroxy-substituted Amino And Ammonium Derivatives And Their Medical UseJan 31, 2023 · US 11,564,895Granted
- Oxygenated Amino- Or Ammonium-containing Sulfonic Acid, Phosphonic Acid And Carboxylic Acid Derivatives And Their Medical UseSep 27, 2022 · US 11,453,642Granted
- Hydroxy-substituted Amino And Ammonium Derivatives And Their Medical UseMar 23, 2021 · US 10,952,977Granted
- Prevention And Treatment Of Inflammatory ConditionsFeb 23, 2021 · US 10,925,886Granted
- Amino- Or Ammonium-containing Sulfonic Acid, Phosphonic Acid And Carboxylic Acid Derivatives And Their Medical UseNov 10, 2020 · US 10,829,506Granted
- Oxygenated Amino- Or Ammonium-containing Sulfonic Acid, Phosphonic Acid And Carboxylic Acid Derivatives And Their Medical UseOct 27, 2020 · US 10,815,195Granted
- Hydroxy-substituted Amino And Ammonium Derivatives And Their Medical UseDec 4, 2018 · US 10,143,668Granted
- Prevention And Treatment Of Inflammatory ConditionsJun 9, 2016 · Application 14964317Pending
- Prevention And Treatment Of Inflammatory ConditionsApplication PCTUS2015063930Pending
- Compositions And Methods For Treating Novel Coronavirus SARS-COV-2-MEDIATED Inflammatory ConditionsApplication PCTUS2021035989Pending
- Compositions and Methods for Treating Novel Coronavirus SARS-CoV-2-mediated Inflammatory ConditionsApplication 63036389Pending
Related companies, and why
- BioEclipse Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Aperiam Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Tentarix Biotherapeutics, LPSimilar federal contract value in Biotech · null in contracts
- Qurgen Inc.Similar federal contract value in Biotech · null in contracts
- Axsome Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Response Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .